{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T01:45:41Z","timestamp":1774921541822,"version":"3.50.1"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA037202"],"award-info":[{"award-number":["T32 DA037202"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30 DA029926"],"award-info":[{"award-number":["P30 DA029926"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Increasingly, treatment for opioid use disorder (OUD) is offered in integrated treatment models addressing both substance use and other health conditions within the same system. This often includes offering medications for OUD in general medical settings. It remains uncertain whether integrated OUD treatment models are preferred to non-integrated models, where treatment is provided within a distinct treatment system. This study aimed to explore preferences for integrated versus non-integrated treatment models among people with OUD and examine what factors may influence preferences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This qualitative study recruited participants (n\u2009=\u200940) through Craigslist advertisements and flyers posted in treatment programs across the United States. Participants were 18\u00a0years of age or older and scored a two or higher on the heroin or opioid pain reliever sections of the Tobacco, Alcohol, Prescription Medications, and Other Substances (TAPS) Tool. Each participant completed a demographic survey and a telephone interview. The interviews were coded and content analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>While some participants preferred receiving OUD treatment from an integrated model in a general medical setting, the majority preferred non-integrated models. Some participants preferred integrated models in theory but expressed concerns about stigma and a lack of psychosocial services. Tradeoffs between integrated and non-integrated models were centered around patient values (desire for anonymity and personalization, fear of consequences), the characteristics of the provider and setting (convenience, perceived treatment effectiveness, access to services), and the patient-provider relationship (disclosure, trust, comfort, stigma).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Among this sample of primarily White adults, preferences for non-integrated versus integrated OUD treatment were mixed. Perceived benefits of integrated models included convenience, potential for treatment personalization, and opportunity to extend established relationships with medical providers. Recommendations to make integrated treatment more patient-centered include facilitating access to psychosocial services, educating patients on privacy, individualizing treatment, and prioritizing the patient-provider relationship. This sample included very few minorities and thus findings may not be fully generalizable to the larger population of persons with OUD. Nonetheless, results suggest a need for expansion of both OUD treatment in specialty and general medical settings to ensure access to preferred treatment for all.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-021-00213-1","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T02:02:42Z","timestamp":1611712962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u201cIt\u2019s way more than just writing a prescription\u201d: A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-0001","authenticated-orcid":false,"given":"Elizabeth C.","family":"Saunders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Budney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Cavazos-Rehg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"213_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). Overdose death rates Atlanta, GA2019 [updated January 2019. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates."},{"key":"213_CR2","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Behavioral Health Statistics and Quality. Treatment Episodes Dataset (TEDS): 2000\u20132010. National admissions to substance abuse treatment services In: U.S. Department of Health and Human Services, editor. Rockville, MD; 2012."},{"key":"213_CR3","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Behavioral Health Statistics and Quality. Treatment Episodes Dataset (TEDS): 2017. Admissions to and discharges from publicly-funded substance use treatment. Rockville, MD; 2019."},{"key":"213_CR4","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey of Substance Abuse Treatment Services (N-SSATS: 2017. Data on substance abuse treatment facilities. Rockville, MD; 2018."},{"key":"213_CR5","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey of Substance Abuse Treatment Services (N-SSATS: 2010-United States. Rockville, MD; 2011."},{"key":"213_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.addbeh.2018.03.012","volume":"86","author":"E Romo","year":"2018","unstructured":"Romo E, Ulbricht CM, Clark RE, Lapane KL. Correlates of specialty substance use treatment among adults with opioid use disorders. Addict Behav. 2018;86:96\u2013103.","journal-title":"Addict Behav"},{"key":"213_CR7","unstructured":"World Health Organization (WHO). International standards for the treatment of drug use disorders. Geneva, CH: United Nations Office on Drugs and Crime; 2017."},{"key":"213_CR8","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. Br J Med . 2017;357:j1550.","journal-title":"Br J Med"},{"key":"213_CR9","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. The Cochrane Database of Systematic Reviews. 2014;2:Cd002207.","DOI":"10.1002\/14651858.CD002207.pub4"},{"issue":"8","key":"213_CR10","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","volume":"105","author":"CM Jones","year":"2015","unstructured":"Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55-63.","journal-title":"Am J Public Health"},{"key":"213_CR11","doi-asserted-by":"publisher","first-page":"107586","DOI":"10.1016\/j.drugalcdep.2019.107586","volume":"204","author":"CL Shover","year":"2019","unstructured":"Shover CL, Humphreys K. Predictors of availability of long-acting medication for opioid use disorder. Drug Alcohol Depend. 2019;204:107586.","journal-title":"Drug Alcohol Depend"},{"issue":"14","key":"213_CR12","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/jama.2015.10345","volume":"314","author":"B Saloner","year":"2015","unstructured":"Saloner B, Karthikeyan S. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004\u2013201. J Am Med Association. 2015;314(14):1515\u20137.","journal-title":"J Am Med Association"},{"key":"213_CR13","volume-title":"The role of community health centers in addressing the opioid epidemic","author":"J Zur","year":"2018","unstructured":"Zur J, Tolbert J, Sharac J, Markus A. The role of community health centers in addressing the opioid epidemic. San Francisco, CA: Kaiser Family Foundation; 2018."},{"issue":"8","key":"213_CR14","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1377\/hlthaff.2011.0480","volume":"30","author":"JA Buck","year":"2011","unstructured":"Buck JA. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff. 2011;30(8):1402\u201310.","journal-title":"Health Aff"},{"issue":"1","key":"213_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archinte.161.1.85","volume":"161","author":"JH Samet","year":"2001","unstructured":"Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: Patient, provider, and societal perspectives. Arch Intern Med. 2001;161(1):85\u201391.","journal-title":"Arch Intern Med"},{"issue":"Suppl 3","key":"213_CR16","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1097\/01.aids.0000192094.84624.c2","volume":"19","author":"ML Willenbring","year":"2005","unstructured":"Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance use disorders: Concepts and approaches. AIDS. 2005;19(Suppl 3):S227\u201337.","journal-title":"AIDS"},{"issue":"6","key":"213_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2105\/AJPH.2019.305080","volume":"109","author":"D McCarty","year":"2019","unstructured":"McCarty D. A changing landscape for treatment of alcohol and drug use disorders. Am J Public Health. 2019;109(6):838\u20139.","journal-title":"Am J Public Health"},{"issue":"12","key":"213_CR18","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/j.1360-0443.2011.03464.x","volume":"106","author":"K Humphreys","year":"2011","unstructured":"Humphreys K, McLellan AT. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction. 2011;106(12):2058\u201366.","journal-title":"Addiction"},{"issue":"7","key":"213_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1056\/NEJMhpr1601861","volume":"375","author":"HA Huskamp","year":"2016","unstructured":"Huskamp HA, Iglehart JK. Mental health and substance-use reforms: Milestones reached, challenges ahead. N Engl J Med. 2016;375(7):688\u201395.","journal-title":"N Engl J Med"},{"issue":"2","key":"213_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.psc.2012.03.004","volume":"35","author":"DR Pating","year":"2012","unstructured":"Pating DR, Miller MM, Goplerud E, Martin J, Ziedonis DM. New systems of care for substance use disorders: Treatment, finance, and technology under health care reform. Psychiatr Clin North Am. 2012;35(2):327\u201356.","journal-title":"Psychiatr Clin North Am"},{"key":"213_CR21","unstructured":"H.R. 34- 21st Century Cures Act, (2016). 114th Congress."},{"key":"213_CR22","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). What is integrated care? Rockville, MD: U.S. Department of Health and Human Services; 2016 https:\/\/www.integration.samhsa.gov\/about-us\/what-is-integrated-care."},{"key":"213_CR23","doi-asserted-by":"publisher","DOI":"10.1599\/EvolvingCare2010","volume-title":"Evolving Models of Behavioral Health Integration in Primary Care","author":"C Collins","year":"2010","unstructured":"Collins C, Hewson DL, Munger R, Wade T. Evolving Models of Behavioral Health Integration in Primary Care. New York, NY: Milbank Memorial Fund; 2010."},{"key":"213_CR24","doi-asserted-by":"crossref","unstructured":"Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, et al. Primary care-based models for the treatment of opioid use disorder: A scoping review. Annals of Internal Medicine. 2016.","DOI":"10.7326\/M16-2149"},{"issue":"10","key":"213_CR25","doi-asserted-by":"publisher","first-page":"e0186315","DOI":"10.1371\/journal.pone.0186315","volume":"12","author":"P Lagisetty","year":"2017","unstructured":"Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE. 2017;12(10):e0186315.","journal-title":"PLoS ONE"},{"issue":"4","key":"213_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.mcna.2018.02.007","volume":"102","author":"EJ Edelman","year":"2018","unstructured":"Edelman EJ, Oldfield BJ, Tetrault JM. Office-based addiction treatment in primary care: Approaches that work. Med Clin North Am. 2018;102(4):635\u201352.","journal-title":"Med Clin North Am"},{"issue":"3\u20134","key":"213_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1037\/h0089174","volume":"13","author":"WJ Doherty","year":"1995","unstructured":"Doherty WJ. The why\u2019s and levels of collaborative family health care. Family Syst Med. 1995;13(3\u20134):275\u201381.","journal-title":"Family Syst Med"},{"issue":"5","key":"213_CR28","first-page":"e194","volume":"65","author":"C Korownyk","year":"2019","unstructured":"Korownyk C, Perry D, Ton J, Kolber MR, Garrison S, Thomas B, et al. Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews. Can Fam Physician. 2019;65(5):e194\u2013206.","journal-title":"Can Fam Physician"},{"issue":"4","key":"213_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.mcna.2018.02.004","volume":"102","author":"CA Pace","year":"2018","unstructured":"Pace CA, Uebelacker LA. Addressing unhealthy substance use in primary care. Medical Clinics North America. 2018;102(4):567\u201386.","journal-title":"Medical Clinics North America"},{"key":"213_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jsat.2019.06.010","volume":"104","author":"NJ Presnall","year":"2019","unstructured":"Presnall NJ, Wolf DAPS, Brown DS, Beeler-Stinn S, Grucza RA. A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings. J Subst Abuse Treat. 2019;104:135\u201343.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"213_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.7326\/M15-0510","volume":"163","author":"RA Crowley","year":"2015","unstructured":"Crowley RA, Kirschner N. The integration of care for mental health, substance abuse, and other behavioral health conditions into primary care: Executive summary of an American College of Physicians position paper. Ann Intern Med. 2015;163(4):298\u20139.","journal-title":"Ann Intern Med"},{"key":"213_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12954-016-0091-4","volume":"13","author":"BX Tran","year":"2016","unstructured":"Tran BX, Nguyen LH, Nong VM, Nguyen CT, Phan HT, Latkin CA. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduction Journal. 2016;13:4.","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"213_CR33","first-page":"33","volume":"12","author":"MR Weaver","year":"2009","unstructured":"Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, et al. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders. J Mental Health Policy Economics. 2009;12(1):33\u201346.","journal-title":"J Mental Health Policy Economics"},{"issue":"3","key":"213_CR34","first-page":"202","volume":"78","author":"V Reynolds","year":"2017","unstructured":"Reynolds V, Causey H, McKee J, Reinstein V, Muzyk A. The role of pharmacists in the opioid epidemic: An examination of pharmacist-focused initiatives across the United States and North Carolina. N C Med J. 2017;78(3):202\u20135.","journal-title":"N C Med J"},{"key":"213_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/SAR.S144268","volume":"8","author":"LT Wu","year":"2017","unstructured":"Wu LT, Ghitza UE, Burns AL, Mannelli P. The opioid overdose epidemic: Opportunities for pharmacists. Substance Abuse Rehabilitation. 2017;8:53\u20135.","journal-title":"Substance Abuse Rehabilitation"},{"key":"213_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1478-4505-10-37","volume":"10","author":"J Henderson","year":"2012","unstructured":"Henderson J, Milligan K, Niccols A, Thabane L, Sword W, Smith A, et al. Reporting of feasibility factors in publications on integrated treatment programs for women with substance abuse issues and their children: A systematic review and analysis. Health Research Policy Syst. 2012;10:37.","journal-title":"Health Research Policy Syst"},{"issue":"4","key":"213_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.chiabu.2011.10.007","volume":"36","author":"A Niccols","year":"2012","unstructured":"Niccols A, Milligan K, Smith A, Sword W, Thabane L, Henderson J. Integrated programs for mothers with substance abuse issues and their children: A systematic review of studies reporting on child outcomes. Child Abuse Negl. 2012;36(4):308\u201322.","journal-title":"Child Abuse Negl"},{"key":"213_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsat.2018.04.008","volume":"90","author":"LA Tarasoff","year":"2018","unstructured":"Tarasoff LA, Milligan K, Le TL, Usher AM, Urbanoski K. Integrated treatment programs for pregnant and parenting women with problematic substance use: Service descriptions and client perceptions of care. J Subst Abuse Treat. 2018;90:9\u201318.","journal-title":"J Subst Abuse Treat"},{"issue":"16","key":"213_CR39","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","volume":"313","author":"G D'Onofrio","year":"2015","unstructured":"D\u2019Onofrio G, O\u2019Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: A randomized clinical trial. J American Med Association. 2015;313(16):1636\u201344.","journal-title":"J American Med Association"},{"key":"213_CR40","doi-asserted-by":"crossref","unstructured":"Hsu YJ, Marsteller JA, Kachur SG, Fingerhood MI. Integration of buprenorphine treatment with primary care: Comparative effectiveness on retention, utilization, and cost. Population Health Management. 2018.","DOI":"10.1089\/pop.2018.0163"},{"issue":"5","key":"213_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.pec.2016.12.019","volume":"100","author":"CM Bastemeijer","year":"2017","unstructured":"Bastemeijer CM, Voogt L, van Ewijk JP, Hazelzet JA. What do patient values and preferences mean? A taxonomy based on a systematic review of qualitative papers. Patient Educ Couns. 2017;100(5):871\u201381.","journal-title":"Patient Educ Couns"},{"key":"213_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.yebeh.2015.10.006","volume":"53","author":"A Fallah","year":"2015","unstructured":"Fallah A. Moving beyond evidence-based medicine: Incorporating patient values and preferences. Epilepsy Behav. 2015;53:209\u201310.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"213_CR43","doi-asserted-by":"publisher","first-page":"e0145817","DOI":"10.1371\/journal.pone.0145817","volume":"11","author":"A Friedrichs","year":"2016","unstructured":"Friedrichs A, Spies M, Harter M, Buchholz A. Patient preferences and shared decision making in the treatment of substance use disorders: A systematic review of the literature. PLoS ONE. 2016;11(1):e0145817.","journal-title":"PLoS ONE"},{"issue":"4","key":"213_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000126073","volume":"77","author":"EA Joosten","year":"2008","unstructured":"Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77(4):219\u201326.","journal-title":"Psychother Psychosom"},{"issue":"8","key":"213_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10597-015-9837-9","volume":"51","author":"V Ede","year":"2015","unstructured":"Ede V, Okafor M, Kinuthia R, Belay Z, Tewolde T, Alema-Mensah E, et al. An examination of perceptions in integrated care practice. Community Ment Health J. 2015;51(8):949\u201361.","journal-title":"Community Ment Health J"},{"issue":"8","key":"213_CR46","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/add.13364","volume":"111","author":"CL Barry","year":"2016","unstructured":"Barry CL, Epstein AJ, Fiellin DA, Fraenkel L, Busch SH. Estimating demand for primary care-based treatment for substance and alcohol use disorders. Addiction. 2016;111(8):1376\u201384.","journal-title":"Addiction"},{"issue":"2","key":"213_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/apc.2013.0179","volume":"28","author":"ML Drainoni","year":"2014","unstructured":"Drainoni ML, Farrell C, Sorensen-Alawad A, Palmisano JN, Chaisson C, Walley AY. Patient perspectives of an integrated program of medical care and substance use treatment. AIDS Patient Care STDs. 2014;28(2):71\u201381.","journal-title":"AIDS Patient Care STDs"},{"issue":"Suppl 1","key":"213_CR48","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1097\/QAI.0b013e3182097561","volume":"56","author":"JE Egan","year":"2011","unstructured":"Egan JE, Netherland J, Gass J, Finkelstein R, Weiss L. Patient perspectives on buprenorphine\/naloxone treatment in the context of HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S46-53.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"213_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsat.2016.07.003","volume":"69","author":"D Nguyen Bich","year":"2016","unstructured":"Nguyen Bich D, Korthuis PT, Nguyen Thu T, Van Dinh H, Le Minh G. HIV patients\u2019 preference for integrated models of addiction and HIV treatment in Vietnam. J Subst Abuse Treat. 2016;69:57\u201363.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"213_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/ADM.0b013e3181cc9610","volume":"4","author":"PT Korthuis","year":"2010","unstructured":"Korthuis PT, Gregg J, Rogers WE, McCarty D, Nicolaidis C, Boverman J. Patients\u2019 reasons for choosing office-based buprenorphine: Preference for patient-centered care. J Addiction Med. 2010;4(4):204\u201310.","journal-title":"J Addiction Med"},{"issue":"1","key":"213_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jsat.2014.07.015","volume":"48","author":"AD Fox","year":"2015","unstructured":"Fox AD, Chamberlain A, Sohler NL, Frost T, Cunningham CO. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants. J Subst Abuse Treat. 2015;48(1):112\u20136.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"213_CR52","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11606-006-0050-y","volume":"22","author":"DT Barry","year":"2007","unstructured":"Barry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O\u2019Connor PG, et al. Patient satisfaction with primary care office-based buprenorphine\/naloxone treatment. J Gen Intern Med. 2007;22(2):242\u20135.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"213_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/08897077.2015.1088496","volume":"37","author":"AD Fox","year":"2016","unstructured":"Fox AD, Masyukova M, Cunningham CO. Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients\u2019 experiences and preferences. Substance Abuse. 2016;37(1):70\u20135.","journal-title":"Substance Abuse"},{"key":"213_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jsat.2020.01.009","volume":"111","author":"EC Saunders","year":"2020","unstructured":"Saunders EC, Moore SK, Walsh O, Metcalf SA, Budney AJ, Scherer E, et al. Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders. J Subst Abuse Treat. 2020;111:54\u201366.","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"213_CR55","doi-asserted-by":"publisher","first-page":"690","DOI":"10.7326\/M16-0317","volume":"165","author":"J McNeely","year":"2016","unstructured":"McNeely J, Wu LT, Subramaniam G, Sharma G, Cathers LA, Svikis D, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for substance use screening in primary care patients. Ann Intern Med. 2016;165(10):690\u20139.","journal-title":"Ann Intern Med"},{"key":"213_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cct.2016.07.013","volume":"50","author":"LT Wu","year":"2016","unstructured":"Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use\/misuse (TAPS) tool. Contemporary Clinical Trials. 2016;50:90\u20137.","journal-title":"Contemporary Clinical Trials"},{"key":"213_CR57","unstructured":"Centers for Disease Control and Prevention (CDC). Drug overdose death data. Atlanta, GA: U.S. Department of Health and Human Services; 2017."},{"issue":"1","key":"213_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0740-5472(98)00006-3","volume":"16","author":"T Weisdorf","year":"1999","unstructured":"Weisdorf T, Parran TV Jr, Graham A, Snyder C. Comparison of pregnancy-specific interventions to a traditional treatment program for cocaine-addicted pregnant women. J Subst Abuse Treat. 1999;16(1):39\u201345.","journal-title":"J Subst Abuse Treat"},{"key":"213_CR59","doi-asserted-by":"publisher","first-page":"107893","DOI":"10.1016\/j.drugalcdep.2020.107893","volume":"209","author":"A Meier","year":"2020","unstructured":"Meier A, Moore SK, Saunders EC, McLeman B, Metcalf SA, Auty S, et al. Understanding the increase in opioid overdoses in New Hampshire: A rapid epidemiologic assessment. Drug Alcohol Depend. 2020;209:107893.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"213_CR60","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1007\/s11606-019-05232-y","volume":"34","author":"EC Saunders","year":"2019","unstructured":"Saunders EC, Moore SK, Gardner T, Farkas S, Marsch LA, McLeman B, et al. Screening for substance use in rural primary care: A qualitative study of providers and patients. J Gen Intern Med. 2019;34(12):2824\u201332.","journal-title":"J Gen Intern Med"},{"key":"213_CR61","doi-asserted-by":"publisher","first-page":"107555","DOI":"10.1016\/j.drugalcdep.2019.107555","volume":"204","author":"E Saunders","year":"2019","unstructured":"Saunders E, Metcalf SA, Walsh O, Moore SK, Meier A, McLeman B, et al. \u201cYou can see those concentric rings going out\u201d: Emergency personnel\u2019s experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire. Drug Alcohol Depend. 2019;204:107555.","journal-title":"Drug Alcohol Depend"},{"key":"213_CR62","unstructured":"NCH Software. Express Scribe Transcription Software, Version 5.87. Greenwood Village, CO; 2016."},{"issue":"3","key":"213_CR63","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nhs.12048","volume":"15","author":"M Vaismoradi","year":"2013","unstructured":"Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nursing Health Sci. 2013;15(3):398\u2013405.","journal-title":"Nursing Health Sci"},{"issue":"9","key":"213_CR64","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res"},{"issue":"7","key":"213_CR65","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/0004867415582053","volume":"49","author":"M Crowe","year":"2015","unstructured":"Crowe M, Inder M, Porter R. Conducting qualitative research in mental health: Thematic and content analyses. Aust N Z J Psychiatry. 2015;49(7):616\u201323.","journal-title":"Aust N Z J Psychiatry"},{"key":"213_CR66","unstructured":"Scientific Software Development GmbH. Atlas.ti, Version 7. Berlin, GER; 2013."},{"key":"213_CR67","first-page":"1","volume":"154","author":"DD Ingram","year":"2012","unstructured":"Ingram DD, Franco SJ. NCHS urban-rural classification scheme for counties. Vital Health Statistics. 2012;154:1\u201365.","journal-title":"Vital Health Statistics"},{"key":"213_CR68","unstructured":"Stoller KB, Stephens MA, Schorr A. Integrated service delivery models for opioid treatment programs in an era of increasing opioid addiction, health reform, and parity. American Association for the Treatment of Opioid Dependence (AATOD); Baltimore, MD: Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services; 2016."},{"key":"213_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsat.2018.11.005","volume":"97","author":"ANC Campbell","year":"2019","unstructured":"Campbell ANC, McCarty D, Rieckmann T, McNeely J, Rotrosen J, Wu LT, et al. Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis. J Subst Abuse Treat. 2019;97:41\u20136.","journal-title":"J Subst Abuse Treat"},{"key":"213_CR70","unstructured":"Nelson WA. Boundary issues in rural America. Overlapping relationships create ethical challenges for rural healthcare professionals. Healthcare Executive. 2010;25(2):56\u20137."},{"issue":"5","key":"213_CR71","first-page":"273","volume":"13","author":"MA Graber","year":"2011","unstructured":"Graber MA. The overlapping roles of the rural doctor. AMA J Ethics Virtual Mentor. 2011;13(5):273\u20137.","journal-title":"AMA J Ethics Virtual Mentor"},{"issue":"2","key":"213_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/13561820600622208","volume":"20","author":"C Brems","year":"2006","unstructured":"Brems C, Johnson ME, Warner TD, Roberts LW. Barriers to healthcare as reported by rural and urban interprofessional providers. J Interprof Care. 2006;20(2):105\u201318.","journal-title":"J Interprof Care"},{"issue":"3","key":"213_CR73","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/02791072.2009.10400539","volume":"41","author":"HS Reisinger","year":"2009","unstructured":"Reisinger HS, Schwartz RP, Mitchell SG, Peterson JA, Kelly SM, O\u2019Grady KE, et al. Premature discharge from methadone treatment: Patient perspectives. J Psychoactive Drugs. 2009;41(3):285\u201396.","journal-title":"J Psychoactive Drugs"},{"key":"213_CR74","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.addbeh.2018.05.002","volume":"84","author":"A Friedrichs","year":"2018","unstructured":"Friedrichs A, Silkens A, Reimer J, Kraus L, Scherbaum N, Piontek D, et al. Role preferences of patients with alcohol use disorders. Addict Behav. 2018;84:248\u201354.","journal-title":"Addict Behav"},{"issue":"1","key":"213_CR75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13011-020-0253-y","volume":"15","author":"K Marchand","year":"2020","unstructured":"Marchand K, Foreman J, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E. Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment. Subst Abuse Treatment Prevention Policy. 2020;15(1):7.","journal-title":"Subst Abuse Treatment Prevention Policy"},{"issue":"1","key":"213_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13011-019-0227-0","volume":"14","author":"K Marchand","year":"2019","unstructured":"Marchand K, Beaumont S, Westfall J, MacDonald S, Harrison S, Marsh DC, et al. Conceptualizing patient-centered care for substance use disorder treatment: Findings from a systematic scoping review. Substance Abuse Treatment Prevention Policy. 2019;14(1):37.","journal-title":"Substance Abuse Treatment Prevention Policy"},{"issue":"4","key":"213_CR77","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMoa055255","volume":"355","author":"DA Fiellin","year":"2006","unstructured":"Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O\u2019Connor PG, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006;355(4):365\u201374.","journal-title":"N Engl J Med"},{"issue":"4","key":"213_CR78","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/ADM.0000000000000236","volume":"10","author":"Schwartz RP.When added to opioid ag","year":"2016","unstructured":"Schwartz RP.When added to opioid agonist treatment, psychosocial interventions do not further reduce the use of illicit opioids: A comment on Dugosh, , et al. J Addict Med. 2016;10(4):283\u20135.","journal-title":"J Addict Med"},{"issue":"2","key":"213_CR79","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","volume":"10","author":"K Dugosh","year":"2016","unstructured":"Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10(2):93\u2013103.","journal-title":"J Addict Med"},{"key":"213_CR80","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12688\/f1000research.10184.1","volume":"6","author":"GE Woody","year":"2017","unstructured":"Woody GE. Advances in the treatment of opioid use disorders. F1000Research. 2017;6:87.","journal-title":"F1000Research."},{"key":"213_CR81","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). TIP 40: Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Rockville, MD: U.S. Department of Health and Human Services,; 2007. Contract No.: SMA07\u20133939."},{"key":"213_CR82","unstructured":"American Society of Addiction Medicine (ASAM). National practice guideline for the use of medications in the treatment of addiction involving opioid use. 2015."},{"issue":"4","key":"213_CR83","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11606-016-3967-9","volume":"32","author":"K Kroenke","year":"2017","unstructured":"Kroenke K, Unutzer J. Closing the false divide: Sustainable approaches to integrating mental health services into primary care. J Gen Intern Med. 2017;32(4):404\u201310.","journal-title":"J Gen Intern Med"},{"issue":"8","key":"213_CR84","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1176\/appi.ajp.2012.11111616","volume":"169","author":"E Woltmann","year":"2012","unstructured":"Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: Systematic review and meta-analysis. Am J Psychiatry. 2012;169(8):790\u2013804.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"213_CR85","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1377\/hlthaff.2018.05134","volume":"37","author":"HA Huskamp","year":"2018","unstructured":"Huskamp HA, Busch AB, Souza J, Uscher-Pines L, Rose S, Wilcock A, et al. How is telemedicine being used in opioid and other substance use disorder treatment? Health Aff. 2018;37(12):1940\u20137.","journal-title":"Health Aff"},{"key":"213_CR86","doi-asserted-by":"crossref","unstructured":"Rubin R. Using telemedicine to treat opioid use disorder in rural areas. The Journal of the American Medical Association. 2019.","DOI":"10.1001\/jama.2019.12574"},{"key":"213_CR87","first-page":"117822181986137","volume":"13","author":"DC Johnston","year":"2019","unstructured":"Johnston DC, Mathews WD, Maus A, Gustafson DH. Using smartphones to improve treatment retention among impoverished substance-using Appalachian women: A naturalistic study. Subst Abuse. 2019;13:1178221819861377.","journal-title":"Subst Abuse"},{"issue":"6","key":"213_CR88","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1037\/a0037496","volume":"82","author":"DR Christensen","year":"2014","unstructured":"Christensen DR, Landes RD, Jackson L, Marsch LA, Mancino MJ, Chopra MP, et al. Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence. J Consult Clin Psychol. 2014;82(6):964\u201372.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"213_CR89","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/10550887.2012.694606","volume":"31","author":"LA Marsch","year":"2012","unstructured":"Marsch LA. Leveraging technology to enhance addiction treatment and recovery. J Addict Dis. 2012;31(3):313\u20138.","journal-title":"J Addict Dis"},{"key":"213_CR90","unstructured":"Marsch LA, Borodovsky JT. Digital health interventions for substance use disorders: The state of the science. In: Miller SC, Fiellin AA, Rosenthal RN, Saitz R, editors. 6th Edition of the ASAM Principles of Addiction Medicine. Philadelphia, PA: Lippincott Williams and Wilkins; 2018."},{"issue":"3","key":"213_CR91","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11606-017-4192-x","volume":"33","author":"DK Back","year":"2018","unstructured":"Back DK, Tammaro E, Lim JK, Wakeman SE. Massachusetts medical students feel unprepared to treat patients with substance use disorder. J Gen Intern Med. 2018;33(3):249\u201350.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"213_CR92","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11606-015-3488-y","volume":"31","author":"YF Chan","year":"2016","unstructured":"Chan YF, Lu SE, Howe B, Tieben H, Hoeft T, Unutzer J. Screening and follow-up monitoring for substance use in primary care: An exploration of rural-urban variations. J Gen Intern Med. 2016;31(2):215\u201322.","journal-title":"J Gen Intern Med"},{"key":"213_CR93","volume-title":"Missed opportunity: National survey of primary care physicians and patients on substance abuse","author":"CASA Columbia","year":"2000","unstructured":"CASA Columbia. Missed opportunity: National survey of primary care physicians and patients on substance abuse. New York, NY: Columbia University; 2000."},{"issue":"10","key":"213_CR94","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1176\/appi.ps.201800378","volume":"70","author":"CB Wolk","year":"2019","unstructured":"Wolk CB, Doubeni CA, Klusaritz HA, Bilger A, Paterson E, Oslin DW. Perspectives and practice in the identification and treatment of opioid use, alcohol use, and depressive disorders. Psychiatric Services. 2019;70(10):940\u20133.","journal-title":"Psychiatric Services"},{"issue":"1","key":"213_CR95","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12875-019-1047-z","volume":"20","author":"DL Louie","year":"2019","unstructured":"Louie DL, Assefa MT, McGovern MP. Attitudes of primary care physicians toward prescribing buprenorphine: A narrative review. BMC Family Practice. 2019;20(1):157.","journal-title":"BMC Family Practice"},{"key":"213_CR96","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugalcdep.2016.05.010","volume":"165","author":"A Kennedy-Hendricks","year":"2016","unstructured":"Kennedy-Hendricks A, Busch SH, McGinty EE, Bachhuber MA, Niederdeppe J, Gollust SE, et al. Primary care physicians\u2019 perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016;165:61\u201370.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"213_CR97","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ajad.12454","volume":"25","author":"FR Levin","year":"2016","unstructured":"Levin FR, Bisaga A, Sullivan MA, Williams AR, Cates-Wessel K. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic. American J Addict. 2016;25(8):603\u20139.","journal-title":"American J Addict"},{"issue":"2","key":"213_CR98","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/ADM.0000000000000200","volume":"10","author":"BR Nordstrom","year":"2016","unstructured":"Nordstrom BR, Saunders EC, McLeman B, Meier A, Xie H, Lambert-Harris C, et al. Using a learning collaborative strategy with office-based practices to increase access and improve quality of care for patients with opioid use disorders. J Addict Med. 2016;10(2):115\u201321.","journal-title":"J Addict Med"},{"key":"213_CR99","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Integration of mental health\/substance abuse and primary care: Evidence report\/techology 173. Washington, DC; 2008."},{"issue":"1","key":"213_CR100","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/08897077.2015.1129388","volume":"37","author":"M Komaromy","year":"2016","unstructured":"Komaromy M, Duhigg D, Metcalf A, Carlson C, Kalishman S, Hayes L, et al. Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders. Subst Abuse. 2016;37(1):20\u20134.","journal-title":"Subst Abuse"},{"key":"213_CR101","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jsat.2019.01.019","volume":"100","author":"D Muthulingam","year":"2019","unstructured":"Muthulingam D, Bia J, Madden LM, Farnum SO, Barry DT, Altice FL. Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support. J Subst Abuse Treat. 2019;100:18\u201328.","journal-title":"J Subst Abuse Treat"},{"key":"213_CR102","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsat.2019.03.005","volume":"101","author":"VA Earnshaw","year":"2019","unstructured":"Earnshaw VA, Bergman BG, Kelly JF. Whether, when, and to whom?: An investigation of comfort with disclosing alcohol and other drug histories in a nationally representative sample of recovering persons. J Subst Abuse Treat. 2019;101:29\u201337.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"213_CR103","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","volume":"16","author":"J Neale","year":"2008","unstructured":"Neale J, Tompkins C, Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community. 2008;16(2):147\u201354.","journal-title":"Health Soc Care Community"},{"key":"213_CR104","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: Health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310.","journal-title":"Int J Drug Policy"},{"key":"213_CR105","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"213_CR106","first-page":"327","volume":"17","author":"JO Merrill","year":"2002","unstructured":"Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: The keys to the \u201cnarc\u201d cabinet. J Gen Intern Med. 2002;17(5):327\u201333.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"213_CR107","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/amiajnl-2011-000432","volume":"19","author":"KM Unertl","year":"2012","unstructured":"Unertl KM, Johnson KB, Lorenzi NM. Health information exchange technology on the front lines of healthcare: Workflow factors and patterns of use. J Am Med Inform Assoc. 2012;19(3):392\u2013400.","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"213_CR108","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12911-017-0436-2","volume":"17","author":"P Esmaeilzadeh","year":"2017","unstructured":"Esmaeilzadeh P, Sambasivan M. Patients\u2019 support for health information exchange: A literature review and classification of key factors. BMC Med Inform Decis Mak. 2017;17(1):33.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"5","key":"213_CR109","doi-asserted-by":"publisher","first-page":"e0177758","DOI":"10.1371\/journal.pone.0177758","volume":"12","author":"GT Kraft-Todd","year":"2017","unstructured":"Kraft-Todd GT, Reinero DA, Kelley JM, Heberlein AS, Baer L, Riess H. Empathic nonverbal behavior increases ratings of both warmth and competence in a medical context. PLoS ONE. 2017;12(5):e0177758.","journal-title":"PLoS ONE"},{"key":"213_CR110","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fpsyt.2019.00475","volume":"10","author":"LC Howe","year":"2019","unstructured":"Howe LC, Leibowitz KA, Crum AJ. When your doctor \u201cGets It\u201d and \u201cGets You\u201d: The critical role of competence and warmth in the patient-provider interaction. Front Psychol. 2019;10:475.","journal-title":"Front Psychol"},{"issue":"1\u20132","key":"213_CR111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC van Boekel","year":"2013","unstructured":"van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"213_CR112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","volume":"107","author":"JD Livingston","year":"2012","unstructured":"Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction. 2012;107(1):39\u201350.","journal-title":"Addiction"},{"issue":"1","key":"213_CR113","doi-asserted-by":"publisher","first-page":"205510291770718","DOI":"10.1177\/2055102917707180","volume":"4","author":"L Brener","year":"2017","unstructured":"Brener L, Cama E, Hull P, Treloar C. Evaluation of an online injecting drug use stigma intervention targeted at health providers in New South Wales, Australia. Health Psychology Open. 2017;4(1):2055102917707180.","journal-title":"Health Psychology Open"},{"issue":"3","key":"213_CR114","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.drugpo.2009.10.010","volume":"21","author":"JF Kelly","year":"2010","unstructured":"Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202\u20137.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"213_CR115","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/07347324.2018.1513777","volume":"37","author":"RD Ashford","year":"2019","unstructured":"Ashford RD, Brown AM, Curtis B. \u201cAbusing addiction\u201d: Our language still isn\u2019t good enough. Alcoholism Treatment Quarterly. 2019;37(2):257\u201372.","journal-title":"Alcoholism Treatment Quarterly"},{"issue":"8","key":"213_CR116","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1080\/10826084.2019.1581221","volume":"54","author":"RD Ashford","year":"2019","unstructured":"Ashford RD, Brown AM, McDaniel J, Curtis B. Biased labels: An experimental study of language and stigma among individuals in recovery and health professionals. Subst Use Misuse. 2019;54(8):1376\u201384.","journal-title":"Subst Use Misuse"},{"issue":"5","key":"213_CR117","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s11606-017-4289-2","volume":"33","author":"AP Goddu","year":"2018","unstructured":"Goddu AP, O\u2019Conor KJ, Lanzkron S, Saheed MO, Saha S, Peek ME, et al. Do words matter Stigmatizing language and the transmission of bias in the medical record. J General Internal Med. 2018;33(5):685\u201391.","journal-title":"J General Internal Med."},{"issue":"5","key":"213_CR118","doi-asserted-by":"publisher","first-page":"e205734","DOI":"10.1001\/jamanetworkopen.2020.5734","volume":"3","author":"DM Schiff","year":"2020","unstructured":"Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Network Open. 2020;3(5):e205734.","journal-title":"JAMA Network Open"},{"issue":"9","key":"213_CR119","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","volume":"76","author":"PA Lagisetty","year":"2019","unstructured":"Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race\/ethnicity and payment. JAMA Psychiatry. 2019;76(9):979\u201381.","journal-title":"JAMA Psychiatry"},{"key":"213_CR120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","volume":"164","author":"H Hansen","year":"2016","unstructured":"Hansen H, Siegel C, Wanderling J, DiRocco D. Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug Alcohol Depend. 2016;164:14\u201321.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"213_CR121","doi-asserted-by":"publisher","first-page":"e0228755","DOI":"10.1371\/journal.pone.0228755","volume":"15","author":"G Pro","year":"2020","unstructured":"Pro G, Zaller N. Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in US healthcare settings. PLoS ONE. 2020;15(2):e0228755.","journal-title":"PLoS ONE"},{"issue":"4","key":"213_CR122","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/15332640.2017.1292418","volume":"16","author":"C McKnight","year":"2017","unstructured":"McKnight C, Shumway M, Masson CL, Pouget ER, Jordan AE, Des Jarlais DC, et al. Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethnicity Subst Abuse. 2017;16(4):404\u201319.","journal-title":"J Ethnicity Subst Abuse"},{"issue":"3","key":"213_CR123","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/PHH.0000000000001168","volume":"26","author":"HV Kunins","year":"2020","unstructured":"Kunins HV. Structural racism and the opioid overdose epidemic: The need for antiracist public health practice. J Public Health Management Practice. 2020;26(3):201\u20135.","journal-title":"J Public Health Management Practice"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-021-00213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13722-021-00213-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-021-00213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T02:04:33Z","timestamp":1611713073000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-021-00213-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1186\/s13722-021-00213-1","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Dartmouth College Committee for the Protection of Human Subjects (CPHS). Participants provided verbal consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}